Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN – Free Report) – Research analysts at Litchfield Hills Research increased their FY2025 earnings per share estimates for Inspira Technologies OXY B.H.N. in a report issued on Monday, July 7th. Litchfield Hills Research analyst T. O’neill now anticipates that the company will post earnings per share of ($0.37) for the year, up from their previous forecast of ($0.38). Litchfield Hills Research has a “Buy” rating on the stock. Litchfield Hills Research also issued estimates for Inspira Technologies OXY B.H.N.’s FY2026 earnings at ($0.13) EPS.
Separately, Wall Street Zen upgraded Inspira Technologies OXY B.H.N. from a “sell” rating to a “hold” rating in a report on Friday, June 27th.
Inspira Technologies OXY B.H.N. Stock Performance
Inspira Technologies OXY B.H.N. stock opened at $1.49 on Wednesday. Inspira Technologies OXY B.H.N. has a 52 week low of $0.40 and a 52 week high of $1.65. The company has a quick ratio of 1.89, a current ratio of 2.02 and a debt-to-equity ratio of 0.09. The company has a 50 day moving average price of $0.71 and a 200 day moving average price of $0.79.
Hedge Funds Weigh In On Inspira Technologies OXY B.H.N.
Several institutional investors have recently added to or reduced their stakes in IINN. Citadel Advisors LLC increased its position in Inspira Technologies OXY B.H.N. by 422.5% in the fourth quarter. Citadel Advisors LLC now owns 86,763 shares of the company’s stock worth $88,000 after purchasing an additional 70,159 shares during the period. Virtu Financial LLC grew its position in Inspira Technologies OXY B.H.N. by 254.4% in the first quarter. Virtu Financial LLC now owns 47,015 shares of the company’s stock valued at $31,000 after purchasing an additional 33,749 shares in the last quarter. Finally, Renaissance Technologies LLC raised its stake in shares of Inspira Technologies OXY B.H.N. by 142.7% during the 4th quarter. Renaissance Technologies LLC now owns 36,622 shares of the company’s stock worth $37,000 after purchasing an additional 21,532 shares in the last quarter. 12.72% of the stock is owned by institutional investors.
About Inspira Technologies OXY B.H.N.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.
Read More
- Five stocks we like better than Inspira Technologies OXY B.H.N.
- How to Calculate Return on Investment (ROI)
- Palantir’s Revenue Surge to $1B: Growth vs. Valuation
- How to Calculate Options Profits
- Alibaba Expands Data Centers Across Asia: A New Growth Catalyst?
- How to Buy Gold Stock and Invest in Gold
- EV Tax Credits Are Ending—Here’s Why These 2 Stocks Could Soar
Receive News & Ratings for Inspira Technologies OXY B.H.N. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspira Technologies OXY B.H.N. and related companies with MarketBeat.com's FREE daily email newsletter.